Diabetes drug metformin might help fight lung cancer
Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows.
Nov 27, 2024
0
40
Neoplasms: News and Research on Carcinoma, Non-Small-Cell Lung
MeSH tree: C04.588.894.797.520.109.220.249
The role of molecular residual disease in operable non-small cell lung cancer with gene fusions
In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify individuals at high risk of disease recurrence and ...
Nov 7, 2024
0
14
Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.
Oct 23, 2024
0
20
Drug improves effectiveness of radiation for lung cancer that has spread to the brain
In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more effective and improve outcomes for patients with lung cancer that has spread to the brain. The ...
Oct 4, 2024
0
26
Mathematical model identifies effective drug combinations for non-small-cell lung cancer
Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer ...
Sep 27, 2024
0
51
Early, virtual palliative care feasible for advanced lung cancer
The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with advanced non-small cell lung cancer (NSCLC), according to a study published online Sept. 11 in the Journal ...
Sep 17, 2024
0
34
Experimental drug helps cancer patients regain weight, study shows
Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.
Sep 16, 2024
0
53
BMI's relation to cancer therapy mortality risks not so straightforward, study finds
While being overweight increases the risk of developing lifestyle-related diseases, there is a phenomenon known as the obesity paradox where a decreased risk of death has been seen during cancer therapy. However, that paradox ...
Sep 12, 2024
0
19
Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations
The tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung cancer across a broad range of EGFR PACC mutations in the first-line metastatic setting with CNS antitumor activity, ...
Sep 9, 2024
0
21
Immunotherapy before and after lung cancer surgery reduces death risk and disease recurrence, research finds
People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns ...
Sep 8, 2024
0
38
